Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates

por Diep, Laetitia, Barbier, Vincent, Doussière, Marie, Touboul, Estelle, Jesson, Claire, Deprez, Valentine, Sobhy-Danial, Jean-Marc, Fardellone, Patrice, Goëb, Vincent
Publicado 2022

Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings

por Philippoteaux, Cécile, Deprez, Valentine, Nottez, Aurore, Cailliau, Emeline, Houvenagel, Eric, Deprez, Xavier, Philippe, Peggy, Pascart, Tristan, Flipo, René-Marc, Goëb, Vincent, Letarouilly, Jean-Guillaume
Publicado 2022

Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life

por Deprez, Valentine, Le Monnier, Laure, Sobhy-Danial, Jean-Marc, Grados, Franck, Henry-Desailly, Isabelle, Salomon-Goëb, Sarah, Rabin, Thibault, Ristic, Sanja, Fumery, Mathurin, Fardellone, Patrice, Goëb, Vincent
Publicado 2020